logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Marvin M Hansen

This inventor holds 12 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1996-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marvin M Hansen. Retrieved from https://idiyas.com/inventor/marvin-m-hansen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 83.3

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:

goldMedal12 out of 4,517 
 
Eli Lilly and Company
 patents

Years Active: 1996-2012

Loading Chart...
12 patents (USPTO):Explore Patents
1. 8153807 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 (2012-04-10),
2. 7144898 - Indole derivatives for the treatment of depression and anxiety (2006-12-05),
3. 6201127 - Process for preparing benzyl-substituted rhodanine derivatives (2001-03-13),
4. 6063799 - Alternate crystal form of Tazofelone (2000-05-16),
5. 6043341 - Cyclic peptide antifungal agents (2000-03-28),
6. 6005142 - Process for preparing benzyl-substituted rhodanine derivatives (1999-12-21),
7. 5986114 - Benzopyranol derivatives (1999-11-16),
8. 5919954 - Stereoselective process for producing dihydro-2,3-benzodiazepine (1999-07-06),
9. 5795886 - Dihydro-2,3-benzodiazepine derivatives (1998-08-18),
10. 5665878 - Stereoselective process for producing dihydro-2,3-benzodiazepine (1997-09-09),
11. 5648492 - Process for preparing isoquinoline compounds (1997-07-15),
12. 5563277 - Process for preparing benzyl-substituted rhodanine derivatives (1996-10-08),

Title: Marvin M Hansen: Innovator in Pharmaceutical Compounds

Introduction

Marvin M Hansen is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work primarily focuses on developing innovative compounds that address various health conditions.

Latest Patents

One of Hansen's latest patents is titled "Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1." This invention discloses novel compounds of Formula I that exhibit 11-HSD type 1 antagonist activity. The patent also includes methods for preparing these compounds and pharmaceutical compositions that utilize them. These compositions are aimed at treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11-HSD type 1 activity.

Another significant patent by Hansen is for "Indole derivatives for the treatment of depression and anxiety." This invention provides compounds of formula (I) that are useful for treating depression and anxiety, as well as alleviating symptoms caused by withdrawal from tobacco or nicotine.

Career Highlights

Marvin M Hansen is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at Eli Lilly has allowed him to contribute to groundbreaking advancements in medicine.

Collaborations

Hansen has collaborated with notable coworkers, including Allen R Harkness and Benjamin Alan Anderson. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Marvin M Hansen is a distinguished inventor whose work has significantly impacted the pharmaceutical field. His innovative patents and collaborations continue to pave the way for advancements in treating various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…